Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of graded inactivated SARS-CoV-2 vaccine in healthy adults and older adults
ChiCTR2100051645Phase 2Recruiting
- Sponsor
- Hunan Provincial Center for Disease Control and Prevention
- Start
- Oct 2021
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of novel coronavirus inactivated vaccine (Vero cells) in coronavirus disease 2019 (COVID-19) (6 arms), sponsored by Hunan Provincial Center for Disease Control and Prevention. Primary endpoint: Humoral immunity. Started Oct 2021; status: recruiting.
02
Drugs
novel coronavirus inactivated vaccine (Vero cells)
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on ChiCTR2100051645.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100051645.